Valuation: CSPC Pharmaceutical Group Limited

Market Cap 92.61B 11.81B 10.32B 9.53B 8.78B 16.55B 1,138B 16.92B 114B 44.78B 557B 44.36B 43.39B 1,918B P/E 2026 *
11.2x
P/E 2027 * 13.1x
Enterprise Value 81.74B 10.43B 9.11B 8.41B 7.75B 14.61B 1,004B 14.93B 100B 39.53B 492B 39.16B 38.3B 1,693B EV / Sales 2026 *
2.29x
EV / Sales 2027 * 2.25x
Free-Float
67.42%
Yield 2026 *
4.49%
Yield 2027 * 4.55%
1 day+4.94%
1 week+4.17%
Current month+21.95%
1 month+24.09%
3 months-5.66%
6 months-12.64%
Current year+0.83%
1 week 7.95
Extreme 7.95
8.72
1 month 6.53
Extreme 6.53
8.72
Current year 6.53
Extreme 6.53
10.96
1 year 6.53
Extreme 6.53
11.63
3 years 4.27
Extreme 4.27
11.63
5 years 4.27
Extreme 4.27
11.9
10 years 3.47
Extreme 3.4687
13.93
Manager TitleAgeSince
Chief Executive Officer 46 2025-12-18
Chief Operating Officer 56 2025-12-18
Corporate Officer/Principal 44 2024-06-30
Director TitleAgeSince
Chairman 72 2011-08-25
Director/Board Member 56 2012-01-19
Director/Board Member 66 2012-12-20
Date Insider Type Main position Quantity % Market Cap.
6/23/26 Other

Chief Operating Officer

-1,400,000 0.0122%
6/23/26 Other

Director

-700,000 0.0061%
6/22/26 Other

Chairman

14,650,000 0.1271%
Change 5-day change 1-year change 3-year change Capi.($)
+4.94%+4.17%-5.56%+35.14% 11.81B
+0.85%-0.80%+52.79%+159.97% 1,051B
+1.23%-1.53%+54.58%+59.41% 609B
+0.04%+2.58%+34.47%+84.84% 450B
-0.10%+0.97%+30.63%+21.95% 330B
-0.90%-0.55%+35.34%+36.23% 284B
-0.30%-0.30%+22.87%+17.54% 263B
+0.77%+2.36%-19.19%-39.86% 223B
-1.42%+0.80%+24.27%+57.85% 198B
-1.48%+3.43%+24.08%+70.06% 167B
Average +0.36%+0.47%+25.43%+50.31% 358.69B
Weighted average by Cap. +0.28%+0.02%+37.60%+77.87%

Financials

2026 *2027 *
Net sales 35.68B 4.55B 3.98B 3.67B 3.38B 6.38B 438B 6.52B 43.86B 17.25B 215B 17.09B 16.71B 739B 35.2B 4.49B 3.92B 3.62B 3.34B 6.29B 432B 6.43B 43.27B 17.02B 212B 16.86B 16.49B 729B
Net income 7.94B 1.01B 885M 816M 753M 1.42B 97.5B 1.45B 9.76B 3.84B 47.75B 3.8B 3.72B 164B 6.92B 882M 771M 711M 656M 1.24B 84.96B 1.26B 8.5B 3.34B 41.61B 3.31B 3.24B 143B
Net Debt -10.86B -1.39B -1.21B -1.12B -1.03B -1.94B -133B -1.98B -13.35B -5.25B -65.35B -5.2B -5.09B -225B -13.44B -1.71B -1.5B -1.38B -1.27B -2.4B -165B -2.45B -16.52B -6.5B -80.85B -6.44B -6.3B -278B
Logo CSPC Pharmaceutical Group Limited
CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The Company is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.
Employees
19,700
Date Price Change Volume
26-07-20 HK$8.500 +4.94% 85,944,318
26-07-17 HK$8.100 -5.81% 143,946,326
26-07-16 HK$8.600 +2.02% 128,510,184
26-07-15 HK$8.430 +3.95% 177,601,778
26-07-14 HK$8.110 -0.61% 103,704,147
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
8.100HKD
Average target price
11.48HKD
Spread / Average Target
+41.79%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1093 Stock